Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tyrosine Kinase Inhibitors. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Explore novel macrocyclic TRK/ALK/ROS1 inhibitors from patent CN111171049B. Overcome drug resistance with high-purity pharmaceutical intermediates and scalable synthesis routes.
Patent CN112359079B reveals a novel enzymatic route for Imatamine. Achieve high purity and cost reduction in API manufacturing with our scalable green chemistry solutions.
Discover the clean production method for 2-fluoro-4-nitrobenzonitrile via patent CN103694137A, offering reduced waste and energy-efficient manufacturing for kinase inhibitors.